Connect With the Teams Shaping Antifibrotic Development Decisions
Significant unmet need persists across lung, liver, kidney, cardiac, skin, gastrointestinal and systemic fibrotic diseases, while recent clinical and regulatory progress is raising expectations for efficacy, safety and differentiation. To move stronger therapies towards clinical proof of concept, biopharma teams need to solve increasingly specific development challenges, from distinguishing disease-driving mechanisms from pathways merely associated with fibrosis, to selecting models that reflect chronic, self-sustaining human disease rather than acute injury.
The 10th Antifibrotic Drug Development Summit returns to Boston as your opportunity to meet decision-makers from fibrosis-focused pharma and biotech working across lung, liver, kidney, cardiac, skin, gastrointestinal and systemic fibrosis. With experts from AbbVie, Arda Therapeutics, aTyr Pharma, Madrigal Pharmaceuticals, Novartis, Pfizer, Takeda Pharmaceutical, Vicore Pharma, Palisade Bio and more, the meeting brings together a broad cross-section of the fibrosis ecosystem in one place.
Position your capabilities in front of teams actively evaluating the technologies, services and development partners needed to strengthen antifibrotic programs, generate relevant commercial opportunities and build lasting relationships across the fibrosis community.
Specialist Capabilities Biopharma Teams Are Looking For
Human-Relevant Fibrosis Models
Chronic disease models, precision-cut tissue slices, organoids and microphysiological systems that better reflect progressive human fibrosis.
Spatial & Multi-Omic Profiling
Single-cell, spatial transcriptomic and proteomic approaches that reveal pathogenic cell states, tissue niches and disease-driving pathways.
Translational Biomarkers & Assays
Tools to demonstrate target engagement, track pathway modulation and detect antifibrotic activity before conventional clinical endpoints change.
Molecular Imaging & Digital Pathology
Non-invasive imaging, quantitative tissue analysis and digital pathology approaches that measure fibrosis burden and treatment response more precisely.
Patient Enrichment & Disease Stratification
Methods that identify patients with the relevant molecular phenotype, active fibrogenesis or rapid-progressor biology to improve trial sensitivity.
Targeted Delivery & Translational Technologies
Platforms that improve tissue or cell selectivity, widen the therapeutic window and help translate promising mechanisms into viable antifibrotic medicines.
What You'll Gain
What to Expect?
Meet New Clients
Expand your client base by networking face-to-face with dedicated attendees actively seeking solutions to overcome their drug development challenges.
Center Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Services & Solutions
Attendees from antifibrotic pharma and biotech are seeking specialist partners that can improve the quality, predictability, and speed of discovery through early clinical development.
Priority capabilities include:
- Human-relevant in vitro, ex vivo & in vivo fibrosis models
- Precision-cut tissue slices, organoids & microphysiological systems
- Biomarker discovery, assay development & validation
- Imaging, digital pathology & quantitative tissue analysis
- Multi-omics, single-cell & spatial biology platforms
- AI-enabled target discovery & translational analytics
- Drug discovery, screening & candidate optimization
- Targeted delivery, formulation & specialist development services
Hear What Our Past Sponsors Have to Say
I enjoyed the quality of scientific exchange and the workshop day interactions
Head Of Business Development & Innovation Manager, Inoviem Scientific
Hanson Wade's team was always available. There were high quality attendees with decision makers present and lots of networking sessions and roundtable discussions
Director - Business Development Drug Discovery & Pharmacology, NovAliX SAS
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Oliver Smare
Partnerships Director
Maintain Your Competitive Edge
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.
Network With Decision-Makers
Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.
Showcase Your Capabilities
Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.